SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-064060
Filing Date
2020-12-17
Accepted
2020-12-17 16:31:17
Documents
2
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1580
2 POA DOCUMENT poa.txt EX-24.3_950740 2971
  Complete submission text file 0001209191-20-064060.txt   6004
Mailing Address 39 ROBINSON ROAD LEXINGTON MA 02420
Business Address
Lawton Alison Frances (Reporting) CIK: 0001542650 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 201396475

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations